Home Newsletters Mammary Cell News Role of CXCL10 in the Progression of In Situ to Invasive Carcinoma...

Role of CXCL10 in the Progression of In Situ to Invasive Carcinoma of the Breast

0
Scientists performed immune profiling to compare immune-related gene expression between ductal carcinoma in situ and invasive carcinoma of the breast using nCounter PanCancer immune Profiling Panel and found that CXCL10 was the most significant gene that had the highest difference in expression between them.
[Scientific Reports]
7992332 {7992332:BBBBBBBB} apa 50 1 166592 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Full Article
Exit mobile version